Literature DB >> 17173099

The Next Generation in Laser Treatments and the Role of the GreenLight High-Performance System Laser.

Alexis E Te.   

Abstract

Lasers have evolved over the past decade, with technical refinements that have resulted in a procedure that can achieve transurethral-like results in a safe and efficacious manner. The physics and characteristics of the laser light, such as wavelength and power densities, influence efficiency of treatment and safety profiles of various laser techniques and systems. The currently commercially available 80-W potassium-titanyl-phosphate laser used for photoselective vaporization of the prostate gland in men with lower urinary tract symptoms and benign prostatic hyperplasia has been shown to be a safe and effective therapeutic alternative for a wide spectrum of prostate sizes and configurations. Refinements based on clinical experience as well as progress in available technologies have produced an advanced system with improvements in beam quality and an increase in power to provide an increase in vaporization efficiency and flexibility in technique. The refinements require adjustments to current technique. The advanced technological developments enhance the utility of this laser for application in benign prostatic hyperplasia and urology.

Entities:  

Year:  2006        PMID: 17173099      PMCID: PMC1686800     

Source DB:  PubMed          Journal:  Rev Urol        ISSN: 1523-6161


  7 in total

Review 1.  The development of laser prostatectomy.

Authors:  A E Te
Journal:  BJU Int       Date:  2004-02       Impact factor: 5.588

2.  Expanding the role of photoselective vaporization of the prostate.

Authors:  Steven A Kaplan
Journal:  Rev Urol       Date:  2006

Review 3.  The evolution of photoselective vaporization prostatectomy (PVP): advancing the surgical treatment of benign prostatic hyperplasia.

Authors:  Richard Lee; Ricardo R Gonzalez; Alexis E Te
Journal:  World J Urol       Date:  2006-05-13       Impact factor: 4.226

4.  Impact of prostate-specific antigen level and prostate volume as predictors of efficacy in photoselective vaporization prostatectomy: analysis and results of an ongoing prospective multicentre study at 3 years.

Authors:  Alexis E Te; Terrence R Malloy; Barry S Stein; James C Ulchaker; Unyime O Nseyo; Mahmood A Hai
Journal:  BJU Int       Date:  2006-06       Impact factor: 5.588

5.  High power potassium-titanyl-phosphate laser vaporization prostatectomy.

Authors:  R S Malek; R S Kuntzman; D M Barrett
Journal:  J Urol       Date:  2000-06       Impact factor: 7.450

6.  High-power potassium-titanyl-phosphate photoselective laser vaporization of prostate for treatment of benign prostatic hyperplasia in men with large prostates.

Authors:  Jaspreet S Sandhu; Casey Ng; Brian A Vanderbrink; Celeste Egan; Steven A Kaplan; Alexis E Te
Journal:  Urology       Date:  2004-12       Impact factor: 2.649

7.  Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: 12-month results from the first United States multicenter prospective trial.

Authors:  Alexis E Te; Terrence R Malloy; Barry S Stein; James C Ulchaker; Unyime O Nseyo; Mahmood A Hai; Reza S Malek
Journal:  J Urol       Date:  2004-10       Impact factor: 7.450

  7 in total
  20 in total

1.  Recent advances in the surgical treatment of benign prostatic hyperplasia.

Authors:  Bernardo Rocco; Giancarlo Albo; Rafael Coelho Ferreira; Matteo Spinelli; Gabriele Cozzi; Paolo Dell'orto; Vipul Patel; Francesco Rocco
Journal:  Ther Adv Urol       Date:  2011-12

2.  Safety and efficacy of the potassium-titanyl-phosphate laser and photoselective vaporization of the prostate for benign prostatic hyperplasia.

Authors:  Claus G Roehrborn
Journal:  Rev Urol       Date:  2006

Review 3.  [GreenLight laser vaporisation of the prostate for treatment of benign prostatic hyperplasia. Development and significance].

Authors:  H-H Seifert; T Hermanns; T Sulser
Journal:  Urologe A       Date:  2008-08       Impact factor: 0.639

Review 4.  Update on photoselective vaporization of the prostate.

Authors:  Petros Sountoulides; Jean J M C H de la Rosette
Journal:  Curr Urol Rep       Date:  2008-03       Impact factor: 3.092

5.  Ablative efficiency of 532-nm laser vaporization compared to transurethral resection of the prostate: results from a prospective three-dimensional ultrasound volumetry study.

Authors:  Thomas Hermanns; Oliver Gross; Benedikt Kranzbühler; Lukas J Hefermehl; Cédric Poyet; Alexander Müller; Stanley A Yap; Maurice S Michel; Daniel Eberli; Michael Müntener; Matthias Zimmermann; Tullio Sulser; Hans-Helge Seifert
Journal:  World J Urol       Date:  2013-10-31       Impact factor: 4.226

6.  New techniques for laser prostatectomy: an update.

Authors:  Doreen E Chung; Alexis E Te
Journal:  Ther Adv Urol       Date:  2009-06

7.  Comparison of 532-nm GreenLight HPS laser with 980-nm diode laser vaporization of the prostate in treating patients with lower urinary tract symptom secondary to benign prostatic hyperplasia: a meta-analysis.

Authors:  Zhongbao Zhou; Yuanshan Cui; Xiaoyi Zhang; Yong Zhang
Journal:  Lasers Med Sci       Date:  2021-01-28       Impact factor: 3.161

8.  Outcome of GreenLight HPS laser therapy in surgically high-risk patients.

Authors:  Chien Hsu Chen; Shung Eing Lin; Po Hui Chiang
Journal:  Lasers Med Sci       Date:  2012-11-23       Impact factor: 3.161

9.  The 532-nm 180-W (GreenLight®) laser vaporization of the prostate for the treatment of lower urinary tract symptoms: how durable is the new side-fire fiber with integrated cooling system?

Authors:  Claus Brunken; Maximilian Munsch; Stephan Tauber; Rainer Schmidt; Christian Seitz
Journal:  Lasers Med Sci       Date:  2013-04-25       Impact factor: 3.161

10.  The application of 120-W high-performance system GreenLight laser vaporization of the prostate in high-risk patients.

Authors:  Wei Tao; BoXin Xue; Yachen Zang; ChuanYang Sun; Dongrong Yang; Yuanyuan Zhang; YuXi Shan
Journal:  Lasers Med Sci       Date:  2012-10-04       Impact factor: 3.161

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.